Details for New Drug Application (NDA): 070295
✉ Email this page to a colleague
NDA 070295 describes METRONIDAZOLE HYDROCHLORIDE, which is a drug marketed by Abraxis Pharm and is included in one NDA. Additional details are available on the METRONIDAZOLE HYDROCHLORIDE profile page.
The generic ingredient in METRONIDAZOLE HYDROCHLORIDE is metronidazole hydrochloride. There are eighteen drug master file entries for this compound. Additional details are available on the metronidazole hydrochloride profile page.
The generic ingredient in METRONIDAZOLE HYDROCHLORIDE is metronidazole hydrochloride. There are eighteen drug master file entries for this compound. Additional details are available on the metronidazole hydrochloride profile page.
Summary for 070295
| Tradename: | METRONIDAZOLE HYDROCHLORIDE |
| Applicant: | Abraxis Pharm |
| Ingredient: | metronidazole hydrochloride |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 500MG BASE/VIAL | ||||
| Approval Date: | Oct 15, 1985 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
